Literature DB >> 7680594

Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.

H Bönisch1, M Barann, J Graupner, M Göthert.   

Abstract

1. The 5-HT3 receptor-mediated cation influx into N1E-115 mouse neuroblastoma cells has been studied by the use of the organic cation [14C]-guanidinium. 2. 5-Hydroxytryptamine (5-HT, 30 microM) caused a time-dependent influx of [14C]-guanidinium which, in contrast to the influx elicited by veratridine (100 microM), was not inhibited by tetrodotoxin (TTX, 10 microM). The 5-HT-induced influx was potentiated by substance P and inhibited by ondansetron. 3. 5-HT and the selective 5-HT3 receptor agonists, m-chloro-phenylbiguanide, phenylbiguanide and 2-methyl-5-HT caused bell-shaped concentration-response curves; the rank order of potency was m-chloro-phenylbiguanide > 5-HT > phenylbiguanide = 2-methyl-5-HT. Among these agonists, 5-HT elicited the highest influx of [14C]-guanidinium. 5-Methoxytryptamine, an agonist at 5-HT4 receptors, showed no effect. 4. The [14C]-guanidinium influx induced by 100 microM 5-HT was not affected by methysergide (10 microM) and ketanserin (10 microM) but was inhibited by 5-HT3 receptor antagonists with the following rank order of potency: ICS 205-930 > ondansetron > MDL 72222 >> metoclopramide. 5. The 5-HT-induced [14C]-guanidinium influx was increased in the absence of Ca2+ and/or Na+ and by a reduction of the temperature from 36 degrees to 20 degrees C. 6. Preincubation with 5-HT (100 microM) caused a time-dependent and rapidly reversible decrease of the 5-HT-induced [14C]-guanidinium influx. 7. It is concluded that [14C]-guanidinium influx measurement in N1E-115 cells is a convenient method to study properties of the cation channel of the 5-HT3 receptor. This influx is independent of the fast sodium channel.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680594      PMCID: PMC1907979          DOI: 10.1111/j.1476-5381.1993.tb12822.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  5-Hydroxytryptamine receptors. An example for the complexity of chemical transmission of information in the brain.

Authors:  M Göthert
Journal:  Arzneimittelforschung       Date:  1992-02

2.  Characterization of 5-HT3 receptors in intact N1E-115 neuroblastoma cells.

Authors:  S C Lummis; G J Kilpatrick; I L Martin
Journal:  Eur J Pharmacol       Date:  1990-09-18       Impact factor: 4.432

Review 3.  5-Hydroxytryptamine receptor subtypes.

Authors:  S J Peroutka
Journal:  Pharmacol Toxicol       Date:  1990-11

4.  The selectivity of the channel coupled to the 5-HT3 receptor.

Authors:  J L Yakel; X M Shao; M B Jackson
Journal:  Brain Res       Date:  1990-11-12       Impact factor: 3.252

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.

Authors:  J L Yakel; M B Jackson
Journal:  Neuron       Date:  1988-09       Impact factor: 17.173

7.  [14C]guanidinium ion influx into Na+ channel preparations from mouse cerebral cortex.

Authors:  M E Reith
Journal:  Eur J Pharmacol       Date:  1990-01-23       Impact factor: 4.432

8.  1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.

Authors:  G J Kilpatrick; A Butler; J Burridge; A W Oxford
Journal:  Eur J Pharmacol       Date:  1990-06-21       Impact factor: 4.432

9.  5-HT3 receptors in NG108-15 neuroblastoma x glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide.

Authors:  F G Boess; M I Sepúlveda; S C Lummis; I L Martin
Journal:  Neuropharmacology       Date:  1992-06       Impact factor: 5.250

10.  AS-5370 potently antagonizes 5-HT3 receptor-mediated responses on NG108-15 cells and on the rat vagus.

Authors:  N R Newberry; T S Sprosen; C J Watkins; R A Leslie; D G Grahame-Smith
Journal:  Eur J Pharmacol       Date:  1992-08-14       Impact factor: 4.432

View more
  7 in total

1.  Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.

Authors:  M Barann; M Göthert; K Fink; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

2.  Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.

Authors:  G J Molderings; K Schmidt; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Increasing effect of ethanol on 5-HT3 receptor-mediated 14C-guanidinium influx in N1E-115 neuroblastoma cells.

Authors:  M Barann; K Ruppert; M Göthert; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

4.  Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Authors:  M Barann; K Schmidt; M Göthert; B W Urban; H Bönisch
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

5.  5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.

Authors:  M Göthert; M Hamon; M Barann; H Bönisch; H Gozlan; R Laguzzi; P Metzenauer; B Nickel; I Szelenyi
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

6.  The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide facilitates noradrenaline release by blockade of alpha 2-adrenoceptors in the mouse brain cortex.

Authors:  E Schlicker; M Kathmann; H J Exner; M Detzner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

Review 7.  Serotonin and beyond-a tribute to Manfred Göthert (1939-2019).

Authors:  H Bönisch; K B Fink; B Malinowska; G J Molderings; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-15       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.